Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Lansky

Showing results (291-300 of 471) with videos related to

Pageof 48
Sort By:
European Heart Journal|March 1, 2005
Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarctionPaul Sorajja, Bernard J Gersh, Costantino Costantini, et al.
The American Journal of Cardiology|October 13, 2004
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarctionDavid E Kandzari, James E Tcheng, Cindy L Grines, et al.
Circulation|September 1, 2010
Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trialNing Guo, Akiko Maehara, Gary S Mintz, et al.
Journal of the American College of Cardiology|July 24, 2010
When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trialsBruce R Brodie, Bernard J Gersh, Thomas Stuckey, et al.
Journal of the American College of Cardiology|August 29, 2009
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stentsAdriano Caixeta, Martin B Leon, Alexandra J Lansky, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 17, 2009
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trialAlexandra J Lansky, Vivian G Ng, Halil Mutlu, et al.
JACC. Cardiovascular Interventions|January 15, 2011
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trialsAdriano Caixeta, Alexandra J Lansky, Patrick W Serruys, et al.
Journal of the American College of Cardiology|February 15, 2005
Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarctionAbhiram Prasad, Gregg W Stone, Thomas D Stuckey, et al.
JACC. Cardiovascular Interventions|July 25, 2009
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) TrialEugenia Nikolsky, Roxana Mehran, H Mehrdad Sadeghi, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|October 3, 2025
Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic DysfunctionGuillaume Marquis-Gravel, Guangyu Tong, Matthew Dodd, et al.
Pageof 48

Showing results (291-300 of 471) with videos related to

Sort By:
Pageof 48
European Heart Journal|March 1, 2005
Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarctionPaul Sorajja, Bernard J Gersh, Costantino Costantini, et al.
The American Journal of Cardiology|October 13, 2004
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarctionDavid E Kandzari, James E Tcheng, Cindy L Grines, et al.
Circulation|September 1, 2010
Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trialNing Guo, Akiko Maehara, Gary S Mintz, et al.
Journal of the American College of Cardiology|July 24, 2010
When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trialsBruce R Brodie, Bernard J Gersh, Thomas Stuckey, et al.
Journal of the American College of Cardiology|August 29, 2009
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stentsAdriano Caixeta, Martin B Leon, Alexandra J Lansky, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 17, 2009
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trialAlexandra J Lansky, Vivian G Ng, Halil Mutlu, et al.
JACC. Cardiovascular Interventions|January 15, 2011
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trialsAdriano Caixeta, Alexandra J Lansky, Patrick W Serruys, et al.
Journal of the American College of Cardiology|February 15, 2005
Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarctionAbhiram Prasad, Gregg W Stone, Thomas D Stuckey, et al.
JACC. Cardiovascular Interventions|July 25, 2009
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) TrialEugenia Nikolsky, Roxana Mehran, H Mehrdad Sadeghi, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|October 3, 2025
Surgical Risk and Long-Term Mortality With PCI and CABG in Ischemic Left Ventricular Systolic DysfunctionGuillaume Marquis-Gravel, Guangyu Tong, Matthew Dodd, et al.
Pageof 48